Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent polypeptide receptor (GIP receptor) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels The activation of the GIP, GLP-1, and GCG receptors simultaneously by retatrutide leads to better weight loss and cardiometabolic benefits compared to targeting a single receptor
It provides 24/7 messaging with LifeMDs care team and on-demand video Doctor visits
Moreover, chronic use of pain medications can lead to dependency or side effects, and surgery doesnt guarantee lasting results if the underlying weight issues persist
There are versions of those drugs Wegovy and Zepbound approved for people with obesity
Retatrutida no est aprobada para uso clnico ni veterinario y los hallazgos clnicos citados corresponden exclusivamente a ensayos registrados patrocinados por su desarrollador
CJC-1295/Ipamorelin = 2 (administered together)